EVISTA – Studies Overview Daniel Thiebaud MD, Medical Fellow, Global Osteoporosis Strategy, Eli Lilly, Australia.
1 Raloxifene for the Reduction in the Risk of Invasive Breast Cancer July 24, 2007 Eli Lilly and Company Oncologic Drugs Advisory Committee Presentation.
